Copyright
©The Author(s) 2022.
World J Clin Pediatr. Mar 9, 2022; 11(2): 136-150
Published online Mar 9, 2022. doi: 10.5409/wjcp.v11.i2.136
Published online Mar 9, 2022. doi: 10.5409/wjcp.v11.i2.136
Gene | Meccanism | Immune assessment | Clinicsautoimmunity | Lymphoproliferation | Infections | Therapy | |
APDS | PIK3CDPIK3R1 | PI3K delta hyperactivation | Hypogammaglobulinemia IgA and IgG lowSenescent CD8 T cellsDNT | IBD; diabetes; arthritis | Lymphadenopathy, splenomegaly | Recurrent respiratory infections; herpes virus infections | HSCT; antibioticsrituximab and rapamycin; PI3Kδ inhibitors |
STAT3 GOF | STAT3 | STAT3 hyperactivation | Hypogammaglobulinemia; decrease NK cells; decrease memory B cells; decrease regulatory T cells | Autoimmune cytopenia; diabetes; thyroiditis; arthritis | Adenopathy, hepatosplenomegaly | Herpes virus infections; fungal infections; bacterial infections; respiratory infections | JACK inhibitors |
APECED | AIRE | Decrease of negative selection of autoreactive T cells in thymus | Autoantibodies;CD8+ effector T cells;FOXP3+ regulatory T cells | Autoimmune hypoparathyroidism;Addison’s disease | Chronic Candida infection | Hormone replacement therapy according to affected organs; immunosuppressive therapies; rituximab | |
CTLA4 deficiency | CTLA4 | Defective switch off of lymphocyte activation | Hypogammaglobulinemia; DNT;increase of regulatory T cells with reduced expression of FOXP3;CD19+ B cells and switched memory B | Autoimmunecytopenia; hemolytic anemia and thrombocytopenia | Splenomegaly;chronic lymphadenopathy;hepatomegaly | Respiratory tract infections | Sirolimus; abatacept; HSCT |
LRBA deficiency | LRBA | Defective switch off of lymphocyte activation | Hypogammaglobulinemia; DNT; FOXP3+regulatory T cells;CD19+ B cells;Natural Killer cells; increase of CD4+ and CD8+ memory T cells | Autoimmune gastritis;autoimmunecytopenia; hemolytic anemia; IBD;Autoimmune enteropathy | Splenomegaly;hepatomegaly | Respiratory infections | sirolimus; abatacept; HSCT |
IPEX | FOXP3 | Failure of immune tolerance | Loss of FOXP3+ T cells;increased of Th2 and Th17 cells;autoantibodiesHypergammaglobulinemia IgA, IgE | Autoimmune enteropathy; autoimmune hemolytic anemia; autoimmune thrombocytopenia; autoimmune neutropenia; autoimmune thyroiditis; nephropathy; hepatitis | Skin infections | Glucocorticoids;Msirolimus;Mtacrolimus; abatacept; HSCT | |
STAT1 GOF | STAT1 | STAT1 hyperactivation due to increase STAT1 phosphorylation | Low Th17 cells; low switched memory B cells;Hypergammaglobulinemia IgG | Chronic mucocutaneous candidiasis; hypothyroidism; autoimmune cytopenia, hepatopathy; psoriasis | Hepatomegaly; splenomegaly | Fungal, viral and mycobacterial infections; skin infections; Respiratory infections | Antifungal treatment; antibiotic prophylaxis; JACK inhibitors |
DADA2 | ADA2 | Reduced activity level of the adenosine deaminase 2 | Hypogammaglobulinemia; increases macrophage release of TNF-α; upregulation of neutrophil activity; upregulation of pro-inflammatory cytokines; upregulation of type 1 interferon stimulated genes; aberrant B cell development and differentiation; decrease in NK | Vasculitis, immunodeficiency; autoimmune neutropenia; autoimmune cytopenia | Splenomegaly; lymphadenopathy; hepatomegaly | Verrucosis; herpes virus infections; increased susceptibility to infection with dsDNA viruses | Anti-TNF treatment (etanercept, infliximab,adalimumab); high-dose of glucocorticoids; HSCT; immunosuppressive drugs in isolated cases (mycophenolate, azathioprine, cyclosporine, rituximab, sirolimus, tacrolimus) |
TNFAIP3 deficiency | TNFAIP3 | Excessive activation of NF-kB signalling | Antinuclear and anti-DNA antibodies; increased production of interferons and proinflammatory cytokines | Autoimmune cytopenias | Anti-TNF treatment; anti-IL1 treatment; glucocorticoid; colchicine |
Clinical red flags |
Early onset in childhood: The development of complex inflammatory disorders before puberty and particularly before early childhood rises suspicion of a congenital immune dysregulation |
Overlap of symptoms in distinct specialties: A clinical history of distinct rheumatologic and non-rheumatologic conditions is not common in pediatrics, addressing a monogenic disorder |
Lymphoproliferative manifestations: The presence of splenomegaly and/or lymphadenopathy in association with inflammatory or autoimmune diseases suggests an underlying inborn error of immunity. |
Recurrent infections: The recurrence of severe or atypical infections (especially candidiasis) in association with inflammatory or autoimmune diseases is rarely a consequence of immunomodulatory therapies in children, but it does suggest an immunological defect |
Familiarity with autoimmunity: The clustering of autoimmune disorders in families acknowledges a likely monogenic cause |
Laboratory red flags |
Hypogammaglobulinemia |
Hypergammaglobulinemia |
Leukopenia |
Hypereosinophilia |
Wide positivity of autoantibodies |
Positive interferon signature |
- Citation: Boz V, Zanchi C, Levantino L, Riccio G, Tommasini A. Druggable monogenic immune defects hidden in diverse medical specialties: Focus on overlap syndromes. World J Clin Pediatr 2022; 11(2): 136-150
- URL: https://www.wjgnet.com/2219-2808/full/v11/i2/136.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v11.i2.136